Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01725054
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
351![]() | 1-(3-{5-[4-(aminomethyl)phenyl]- 1H-pyrrolo[2,3-b]pyridin-3-yl}phenyl)- 3-(2-phenoxyphenyl)urea | A,B | 3ETA | 0.7 | ![]() |
253![]() | 10,11-dimethoxy-4-methyldibenzo[c,f]- 2,7-naphthyridine-3,6-diamine | A | 2R7B | 0.7 | ![]() |
2S8![]() | (2S)-8-[(tert-butoxycarbonyl)amino]- 2-(1H-indol-3-yl)octanoic acid | B | 3C6N | 0.71 | ![]() |
2PY![]() | (2S)-1-{[5-(1H-INDAZOL-5-YL)PYRIDIN- 3-YL]OXY}-3-[(7AS)-7AH-INDOL-3- YL]PROPAN-2-AMINE | E | 2OH0 | 0.74 | ![]() |
232![]() | 1,3-DI[[[10-METHOXY-7H-PYRIDO[4,3- C]CARBAZOL-2-IUMYL]-ETHYL]-PIPERIDIN- 4-YL]-PROPANE | A | 1C9Z | 0.73 | ![]() |
2S3![]() | (2S)-2-(1H-indol-3-yl)pentanoic acid | B | 3C6P | 0.72 | ![]() |
43A![]() | (3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)- 3-(1H-PYRROL-2-YLMETHYLENE)-1,3- DIHYDRO-2H-INDOL-2-ONE | A | 2AYP | 0.75 | ![]() |
124![]() | 2-(2-HYDROXY-PHENYL)-1H-INDOLE- 5-CARBOXAMIDINE | A | 1GI6 | 0.72 | ![]() |
3ID![]() | 3H-INDOLE-5,6-DIOL | A | 1F9B | 0.83 | ![]() |
3ID![]() | 3H-INDOLE-5,6-DIOL | A | 1OYO | 0.83 | ![]() |
3IP![]() | 3-(BENZYLOXY)PYRIDIN-2-AMINE | A | 1W7H | 0.7 | ![]() |
1TQ![]() | 6-(FORMYLAMINO)-7-HYDROXY-L-TRYPTOPHAN | D,H | 2OK6 | 0.72 | ![]() |
1TQ![]() | 6-(FORMYLAMINO)-7-HYDROXY-L-TRYPTOPHAN | D,H | 2I0R | 0.72 | ![]() |
320![]() | 2-(4-fluorophenyl)-N-{[3-fluoro- 4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide | A | 3CTJ | 0.7 | ![]() |
0AF![]() | 7-hydroxy-L-tryptophan | L | 1MAE | 0.75 | ![]() |
0AF![]() | 7-hydroxy-L-tryptophan | L | 1MAF | 0.75 | ![]() |
215![]() | (1Z)-5-(2-{4-[2-(DIMETHYLAMINO)ETHOXY]PHENYL}- 5-PYRIDIN-4-YL-1H-IMIDAZOL-4-YL)INDAN- 1-ONE OXIME | A,B | 2FB8 | 0.7 | ![]() |
2EA![]() | (1S)-2-(1H-INDOL-3-YL)-1-{[(5-ISOQUINOLIN- 6-YLPYRIDIN-3-YL)OXY]METHYL}ETHYLAMINE | E | 2F7E | 0.73 | ![]() |
134![]() | 6-FLUORO-2-[2-HYDROXY-3-(2-METHYL- CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE- 5-CARBOXAMIDINE | B | 1GJ9 | 0.78 | ![]() |
3IL![]() | 3-(INDOL-3-YL) LACTATE | A | 2A7P | 0.75 | ![]() |
2S2![]() | (2S)-2-(1H-indol-3-yl)hexanoic acid | B | 3C6O | 0.72 | ![]() |
3FP![]() | (2R)-1-(DIMETHYLAMINO)-3-{4-[(6- {[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN- 4-YL)AMINO]PHENOXY}PROPAN-2-OL | A | 1V1K | 0.7 | ![]() |
3LG![]() | (5-{[(2R)-1-(4-{3-[(2-METHOXYBENZYL)OXY]PROPOXY}PHENYL)- 6-OXOPIPERAZIN-2-YL]METHOXY}-1H- INDOL-1-YL)ACETIC ACID | B | 2G26 | 0.8 | ![]() |